Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hema Liyanage"'
Autor:
Hema Liyanage, Luigi Scotto, Catherine Do, Benjamin Tycko, Owen A. O'Connor, Vundavalli V. Murty, Gopeshwar Narayan, Sergey Kisselev, Lorraine N. Clark, Allen J. Freddy, Govind Bhagat, Bachir Alobeid, Ganchimeg Ishdorj, Subhadra V. Nandula, Prakash Satwani, Dongxu Xie, David G. Savage
Publikováno v:
Genes, Chromosomes and Cancer. 52:1030-1041
PCDH10 is epigenetically inactivated in multiple tumor types; however, studies in mature lymphoid malignancies are limited. Here, we have investigated the presence of promoter hypermethylation of the PCDH10 gene in a large cohort of well-characterize
Autor:
Elizabeth A. Maher, Balazs Halmos, Matthew Meyerson, Jeffrey C. Lee, Neal I. Lindeman, Victoria A. Joshi, Robert J. Distel, Pasi A. Jänne, Andrew M. Rogers, Ana M. Borras, Bruce E. Johnson, Hema Liyanage, Yanan Kuang
Publikováno v:
Clinical Cancer Research. 12:751-758
Purpose: Mutations in the epidermal growth factor receptor (EGFR) are associated with clinical and radiographic responses to EGFR tyrosine kinase inhibitors gefitinib and erlotinib. Currently available methods of EGFR mutation detection rely on direc
Autor:
Vernadette Simon, Yanan Yang, Hyo Sung Jeon, Jin Jen, Robert B. Diasio, Karla J. Kopp, Yan W. Asmann, Yuta Sakai, Michele R. Erickson-Johnson, Peter W. Li, Andre M. Oliveira, Hayoung Hwang, Jin Sung Jang, Dennis A. Wigle, Hema Liyanage, Zhifu Sun, Eric D. Wieben, Adam M. Lee, Lixia Guo, Marie Christine Aubry, Aaron O. Bungum, Bruce W. Eckloff, Ping Yang, Eunhee S. Yi, Jun Li, Eric S. Edell
Publikováno v:
Scientific Reports
Lung adenocarcinomas from never smokers account for approximately 15 to 20% of all lung cancers and these tumors often carry genetic alterations that are responsive to targeted therapy. Here we examined mutation status in 10 oncogenes among 89 lung a
Autor:
Gopeshwar, Narayan, Dongxu, Xie, Allen J, Freddy, Ganchimeg, Ishdorj, Catherine, Do, Prakash, Satwani, Hema, Liyanage, Lorraine, Clark, Sergey, Kisselev, Subhadra V, Nandula, Luigi, Scotto, Bachir, Alobeid, David, Savage, Benjamin, Tycko, Owen A, O'Connor, Govind, Bhagat, Vundavalli V, Murty
Publikováno v:
Genes, chromosomescancer. 52(11)
PCDH10 is epigenetically inactivated in multiple tumor types; however, studies in mature lymphoid malignancies are limited. Here, we have investigated the presence of promoter hypermethylation of the PCDH10 gene in a large cohort of well-characterize
Autor:
Lauren Higgins, Shannon McClelland, Edward Yeh, Danielle Durie, Hema Liyanage, Michael Pluscauskas, Stacey Weber, Mylene Theriault, Pranesh Chakraborty, Martyn L. Hyde, Dennis E. Bulman
Publikováno v:
Journal of Medical Genetics. 52:A8.1-A8
Background The Ontario Infant Hearing Program identifies babies born with, or at risk for, permanent hearing impairment. The current method of audiometric screening may be limited in detecting forms of hearing impairment, which are clinically silent
Autor:
Gopeshwar Narayan, David G. Savage, Catherine E. McGuinn, Allen J. Freddy, Subhadra V. Nandula, Vundavalli V. Murty, Bachir Alobeid, Dongxu Xie, Hema Liyanage, Prakash Satwani, Govind Bhagat, Sergey Kisselev, Lorraine N. Clark, Shivakumar Subramaniyam, Ji Un Kang
Publikováno v:
Genes, chromosomescancer. 50(12)
PCDH10has been implicated as a tumor suppressor, since epigenetic alterations of this gene have been noted in multiple tumor types. However, to date, studies regarding its role in acute and chronic leukemias are lacking. Here, we have investigated th